Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neonorm Dog is a plant-based, non-prescription animal health product developed by Jaguar Health, Inc. It is formulated with a standardized botanical extract derived from the *Croton lechleri* tree, commonly known as "Dragon's Blood." The product is designed to support normal stool consistency and gastrointestinal fluid balance in dogs by acting locally in the gut. Unlike systemic treatments, Neonorm Dog is not absorbed into the bloodstream and serves as a non-antibiotic option for managing loose stools and hydration concerns in canine patients. It is part of Jaguar's Neonorm franchise, which includes similar products for calves and foals, and is positioned for distribution through retail and online animal health channels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neonorm Dog.